HealthOctober 05, 2021

Webinar: Update on recent proposed revisions to USP Chapters 795 and 797

This past September, the United States Pharmacopeia (USP) issued a long-awaited Notice of Intent to Revise (NITR) for both USP Chapter 795 and USP Chapter 797.  

The United States Pharmacopeia (USP) Chapters <795> and <797> have been under review for the better part of a decade. The iterative process around updating the standards has led to unresolved guidance and confusion in the compounding community.

This webinar was designed to help you process these latest proposed September 1, 2021 revisions. Simplifi 797 compounding compliance expert, Annie Lambert, PharmD, BCSCP, will:

  • Provide a summary of key changes in the newest revisions to both USP <795> and <797>.
  • Give an update on issues discussed at the September stakeholder forums.
  • Present action steps for assessing the potential impact on your compounding practice. 

Access the webinar

Annie Lambert
Clinical Program Manager for Compliance Solutions
Compliance Solution Clinical Program Manager Annie Lambert, PharmD, BCSCP is committed to providing up-to-date USP content and expert compliance guidance, and to work with you to optimize the use of our solutions.
Solutions
Simplifi 797®

Take the guesswork out of USP medication compounding compliance with a customizable, mobile, evidence-based solution.

Simplifi 797 provides the latest evidence-based guidance and helps navigate the complex USP Chapters 795, 797 and 800 processes to ensure inspection confidence and keep patients and staff safe.
Back To Top